Global EditionASIA 中文双语Français
Home / China / Health

XBB subvariants not dominant in China: expert

China Daily | Updated: 2023-01-09 09:49
Share - WeChat
A medical worker in a protective suit adjusts a monitoring device for a patient at the fever clinics of the Third Hospital of Hebei Medical University. [Photo by Wang Zhuangfei/China Daily]

BEIJING -- The COVID-19 Omicron XBB subvariants have not developed into dominant subvariants in China and will not cause a large-scale epidemic in the country at the current stage, according to an expert with the Chinese Center for Disease Control and Prevention (China CDC).

Chen Cao, research fellow with the National Institute for Viral Disease Control and Prevention under the China CDC, shared the information at a Sunday press conference held by the State Council joint prevention and control mechanism against COVID-19.

Noting the increasing risks of imported cases caused by XBB subvariants, Chen said the antibodies produced by individuals recently infected with BA.5.2 and BF.7 sub-strains will protect them from XBB subvariants to some extent.

In the meantime, the country has further strengthened the monitoring system on novel coronavirus variants and prepared targeted response plans, said Chen.

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349